P2Y2 Receptor Signaling in Health and Disease
International Journal of Molecular Sciences · 09.10.2025 · 26 (19) · 9815
DOI: 10.3390/ijms26199815 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.10.2025. Verfasst von Fatemeh Salarpour und 1 weiteren Autor:innen. Beteiligte Einrichtung: Département de Microbiologie-Infectiologie et D'immunologie, Centres PROTEO et ARThrite, Faculté de Médecine, Université Laval, Québec City, QC G1V 0…. Hauptthemen laut MEDLINE: Receptors, Purinergic P2Y2, Signal Transduction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Fonds de recherche du Québec (FRQ) through the research centre grant for the CHU de Québec-Université Laval Re-search Center, Canadian Institutes of Health Research.
Abstract (Originalsprache)
P2Y2 receptors are a subclass of G protein-coupled receptors activated by the extracellular nucleotides ATP and UTP. These receptors are widely expressed in multiple tissues—including the brain, lungs, heart, and kidneys—and play pivotal roles in inflammation, wound healing, and cell migration. Through coupling with various G proteins, P2Y2 receptors initiate diverse intracellular signaling pathways that mediate calcium mobilization, cytokine release, and cytoskeletal reorganization. Recent studies highlight their dual roles in health and disease. In physiological contexts, P2Y2 receptors contribute to immune modulation and tissue repair. In pathological conditions, they are implicated in Alzheimer’s disease by promoting non-amyloidogenic processing of amyloid precursor protein and in dry eye disease by enhancing mucin secretion while modulating ocular inflammation. They also influence chloride secretion and mucosal hydration in cystic fibrosis and contribute to inflammatory regulation and epithelial repair in inflammatory bowel disease. Additionally, P2Y2 receptors modulate breast cancer progression by regulating cell adhesion, migration, and matrix remodeling. Their involvement in blood pressure regulation via epithelial sodium channel modulation and their facilitative role in HIV-1 entry further underscore their clinical significance. These multifaceted functions position P2Y2 receptors as promising therapeutic targets for diverse diseases, warranting further investigation for translational applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de Microbiologie-Infectiologie et D'immunologie, Centres PROTEO et ARThrite, Faculté de Médecine, Université Laval, Québec City, QC G1V 0A6, Canada.
- Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec Université Laval, Québec City, QC G1V 4G2, Canada.
ORCID-Profile: Jean Sévigny
Förderung
- CIHR
- Fonds de recherche du Québec (FRQ) through the research centre grant for the CHU de Québec-Université Laval Re-search Center
- Canadian Institutes of Health Research
- Fonds de recherche du Québec (FRQ) through the research center grant for the CHU de Québec–Université Laval Research Center
- Université Laval Studentship (Citizens of the World Doctoral Commitment Scholarship) as well as a Vanier Canada Graduate Scholarship
Zitieren
APA
Salarpour, F., & Sévigny, J. (2025). P2Y2 Receptor Signaling in Health and Disease. International Journal of Molecular Sciences, 26(19), 9815. https://doi.org/10.3390/ijms26199815
Vancouver
Salarpour F, Sévigny J. P2Y2 Receptor Signaling in Health and Disease. International Journal of Molecular Sciences. 2025;26(19):9815. doi:10.3390/ijms26199815
BibTeX
@article{Salarpour2025,
author = {Salarpour, Fatemeh and Sévigny, Jean},
title = {P2Y2 Receptor Signaling in Health and Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9815},
doi = {10.3390/ijms26199815}
}
EUVIMED